ADIPOQ and Hyperinsulinemia: These promote chronic low‐grade inflammation, insulin resistance, and hyperinsulinemia, which enhance colonic epithelial proliferation and adenoma formation via pathways like IGF‐1 signaling and adipokine dysregulation (e.g., elevated leptin and reduced adiponectin) [31].